Boston Scientific Betting $1.5 Billion: Market Bets and Implications
A bold $1.5 billion investment signals Boston Scientific’s shift into transcatheter aortic valve replacement. Explore...
This section highlights volatility metrics for the dividend aristocrats ETF, offering key indicators to monitor risk and potential entry points.
22,062 articlesA bold $1.5 billion investment signals Boston Scientific’s shift into transcatheter aortic valve replacement. Explore...
An AI-focused stock rocks the market with a standout rally, prompting traders to reassess where AI breakthroughs are ...
Ethereum breached a critical support level, signaling renewed downside risk. This report breaks down the factors, key...
What a difference a year makes. Last year, Wall Street questioned this AI stock’s valuation. Today, analysts anticipa...
Rivian unveiled a new entry SUV meant to broaden its addressable market, but the stock slid as investors question whe...
Ethereum hovers near a pivotal price zone as traders await a breakout. A decisive move above the key level could spar...
When a space company hits the public markets, unexpected names can move too. This article explains why sandisk stock ...
As Nvidia signals AI momentum and Marvell rides the wave, investors scan AI bookings and data-center demand to gauge ...
OpenAI's Sam Altman projects a future where AI outperforms human intellect by 2030, while rivals push for quicker tim...
U.S. stocks attempt to regain momentum on June 24, 2026, as investors digest fresh earnings and AI demand signals. Th...
A Live Oak Bancshares director sold 8,400 shares for about $336,000. Learn what this kind of insider action can signa...
Bitwise CIO Matt Hougan argues that Strategy's STRC selloff reflects end-of-cycle deleveraging preceding a bitcoin bo...